NasdaqGS:EVCMSoftware
Evaluating EverCommerce (EVCM) After Earnings Turnaround And EverHealth Scribe AI Launch
EverCommerce (EVCM) drew investor attention after reporting fourth quarter and full year 2025 results that shifted from prior net losses to net income, alongside the launch of its EverHealth Scribe AI documentation tool.
See our latest analysis for EverCommerce.
The swing to net income and the EverHealth Scribe launch come after a 90 day share price decline of 14.39% and a year to date share price decline of 10.39%. In contrast, the 1 year total shareholder return of 2.68% and 3 year total...